Skip to main content
Premium Trial:

Request an Annual Quote

Ardais Raises $13.4 Million in Series C

NEW YORK, Feb. 25 - Ardais, of Lexington, Mass., said today it has raised $13.4 million in a series C round of financing.  


The clinical genomics company plans to use the proceeds of its financing to "grow the company's business, and expand its clinical genomics capabilities to enhance productivity throughout the continuum of drug discovery and development," CEO Gregory Phelps said in a statement.


The financing was led by a group of existing investors, including The Kaufmann Fund, Advanced Technology Ventures, Advent Health Care and Life Sciences, EGS Healthcare Capital Partners, Bessemer Venture Partners, Pequot Private Equity Fund, BioVentures Investors, and Silicon Valley Bancshares.


This brings the total the company has raised to over $47 million. In March 2001, the company closed a $33.5 million series B round of financing, following its initial seed round in 2000.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.